Literature DB >> 22526145

Probiotic factors partially prevent changes to caspases 3 and 7 activation and transepithelial electrical resistance in a model of 5-fluorouracil-induced epithelial cell damage.

Luca D Prisciandaro1, Mark S Geier, Ann E Chua, Ross N Butler, Adrian G Cummins, Guy R Sander, Gordon S Howarth.   

Abstract

The potential efficacy of a probiotic-based preventative strategy against intestinal mucositis has yet to be investigated in detail. We evaluated supernatants (SN) from Escherichia coli Nissle 1917 (EcN) and Lactobacillus rhamnosus GG (LGG) for their capacity to prevent 5-fluorouracil (5-FU)-induced damage to intestinal epithelial cells. A 5-day study was performed. IEC-6 cells were treated daily from days 0 to 3, with 1 mL of PBS (untreated control), de Man Rogosa Sharpe (MRS) broth, tryptone soy roth (TSB), LGG SN, or EcN SN. With the exception of the untreated control cells, all groups were treated with 5-FU (5 μM) for 24 h at day 3. Transepithelial electrical resistance (TEER) was determined on days 3, 4, and 5, while activation of caspases 3 and 7 was determined on days 4 and 5 to assess apoptosis. Pretreatment with LGG SN increased TEER (p < 0.05) compared to controls at day 3. 5-FU administration reduced TEER compared to untreated cells on days 4 and 5. Pretreatment with MRS, LGG SN, TSB, and EcN SN partially prevented the decrease in TEER induced by 5-FU on day 4, while EcN SN also improved TEER compared to its TSB vehicle control. These differences were also observed at day 5, along with significant improvements in TEER in cells treated with LGG and EcN SN compared to healthy controls. 5-FU increased caspase activity on days 4 and 5 compared to controls. At day 4, cells pretreated with MRS, TSB, LGG SN, or EcN SN all displayed reduced caspase activity compared to 5-FU controls, while both SN groups had significantly lower caspase activity than their respective vehicle controls. Caspase activity in cells pretreated with MRS, LGG SN, and EcN SN was also reduced at day 5, compared to 5-FU controls. We conclude that pretreatment with selected probiotic SN could prevent or inhibit enterocyte apoptosis and loss of intestinal barrier function induced by 5-FU, potentially forming the basis of a preventative treatment modality for mucositis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22526145     DOI: 10.1007/s00520-012-1446-3

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  30 in total

1.  Bifidobacterium lactis attenuates onset of inflammation in a murine model of colitis.

Authors:  David Philippe; Laurent Favre; Francis Foata; Oskar Adolfsson; Genevieve Perruisseau-Carrier; Karine Vidal; Gloria Reuteler; Johanna Dayer-Schneider; Christoph Mueller; Stéphanie Blum
Journal:  World J Gastroenterol       Date:  2011-01-28       Impact factor: 5.742

2.  Uptake and metabolism of plasma glutamine by the small intestine.

Authors:  H G Windmueller; A E Spaeth
Journal:  J Biol Chem       Date:  1974-08-25       Impact factor: 5.157

3.  Probiotic factors partially improve parameters of 5-fluorouracil-induced intestinal mucositis in rats.

Authors:  Luca D Prisciandaro; Mark S Geier; Ross N Butler; Adrian G Cummins; Gordon S Howarth
Journal:  Cancer Biol Ther       Date:  2011-04-01       Impact factor: 4.742

4.  Glutamine deprivation alters intestinal tight junctions via a PI3-K/Akt mediated pathway in Caco-2 cells.

Authors:  Nan Li; Josef Neu
Journal:  J Nutr       Date:  2009-02-11       Impact factor: 4.798

5.  Probiotics ameliorate the hydrogen peroxide-induced epithelial barrier disruption by a PKC- and MAP kinase-dependent mechanism.

Authors:  A Seth; Fang Yan; D Brent Polk; R K Rao
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-02-21       Impact factor: 4.052

6.  Effects of multispecies probiotic combination on helicobacter pylori infection in vitro.

Authors:  E Myllyluoma; A-M Ahonen; R Korpela; H Vapaatalo; E Kankuri
Journal:  Clin Vaccine Immunol       Date:  2008-06-25

7.  Substitutes for glutamine in proliferation of rat intestinal epithelial cells.

Authors:  Lauren M Tuhacek; Amy D Mackey; Nan Li; Vincent G DeMarco; Gary Stevens; Josef Neu
Journal:  Nutrition       Date:  2004-03       Impact factor: 4.008

Review 8.  Oral and intestinal mucositis - causes and possible treatments.

Authors:  M Duncan; G Grant
Journal:  Aliment Pharmacol Ther       Date:  2003-11-01       Impact factor: 8.171

9.  The probiotic Lactobacillus GG may augment intestinal host defense by regulating apoptosis and promoting cytoprotective responses in the developing murine gut.

Authors:  Patricia W Lin; Tala R Nasr; Andrew J Berardinelli; Amrita Kumar; Andrew S Neish
Journal:  Pediatr Res       Date:  2008-11       Impact factor: 3.756

Review 10.  The role of pro-inflammatory cytokines in cancer treatment-induced alimentary tract mucositis: pathobiology, animal models and cytotoxic drugs.

Authors:  Richard M Logan; Andrea M Stringer; Joanne M Bowen; Ann S-J Yeoh; Rachel J Gibson; Stephen T Sonis; Dorothy M K Keefe
Journal:  Cancer Treat Rev       Date:  2007-05-15       Impact factor: 12.111

View more
  17 in total

1.  Live and heat-killed Lactobacillus rhamnosus GG upregulate gene expression of pro-inflammatory cytokines in 5-fluorouracil-pretreated Caco-2 cells.

Authors:  Shiuh-Bin Fang; Hsin-Yu Shih; Chih-Hung Huang; Li-Ting Li; Chia-Chun Chen; Hsu-Wei Fang
Journal:  Support Care Cancer       Date:  2014-02-06       Impact factor: 3.603

2.  Lactobacillus rhamnosus CNCM I-3690 and the commensal bacterium Faecalibacterium prausnitzii A2-165 exhibit similar protective effects to induced barrier hyper-permeability in mice.

Authors:  L Laval; R Martin; J N Natividad; F Chain; S Miquel; C Desclée de Maredsous; S Capronnier; H Sokol; E F Verdu; J E T van Hylckama Vlieg; L G Bermúdez-Humarán; T Smokvina; P Langella
Journal:  Gut Microbes       Date:  2015-01-14

3.  Escherichia coli Nissle 1917-derived factors reduce cell death and late apoptosis and increase transepithelial electrical resistance in a model of 5-fluorouracil-induced intestinal epithelial cell damage.

Authors:  Hanru Wang; Susan E P Bastian; Ker Y Cheah; Andrew Lawrence; Gordon S Howarth
Journal:  Cancer Biol Ther       Date:  2014-02-20       Impact factor: 4.742

4.  Autochthonous Bacterial Isolates Successfully Stimulate In vitro Peripheral Blood Leukocytes of the European Sea Bass (Dicentrarchus labrax).

Authors:  Ivona Mladineo; Ivana Bušelić; Jerko Hrabar; Ivana Radonić; Anamarija Vrbatović; Slaven Jozić; Željka Trumbić
Journal:  Front Microbiol       Date:  2016-08-08       Impact factor: 5.640

Review 5.  Evidence of the Anti-Inflammatory Effects of Probiotics and Synbiotics in Intestinal Chronic Diseases.

Authors:  Julio Plaza-Díaz; Francisco Javier Ruiz-Ojeda; Laura Maria Vilchez-Padial; Angel Gil
Journal:  Nutrients       Date:  2017-05-28       Impact factor: 5.717

Review 6.  Use of Wild Type or Recombinant Lactic Acid Bacteria as an Alternative Treatment for Gastrointestinal Inflammatory Diseases: A Focus on Inflammatory Bowel Diseases and Mucositis.

Authors:  Rodrigo D De Oliveira Carvalho; Fillipe L R do Carmo; Alberto de Oliveira Junior; Philippe Langella; Jean-Marc Chatel; Luis G Bermúdez-Humarán; Vasco Azevedo; Marcela S de Azevedo
Journal:  Front Microbiol       Date:  2017-05-09       Impact factor: 5.640

Review 7.  Role of endogenous microbiota, probiotics and their biological products in human health.

Authors:  Gordon S Howarth; Hanru Wang
Journal:  Nutrients       Date:  2013-01-10       Impact factor: 5.717

8.  Antarctic Strain of Rhodotorula mucilaginosa UFMGCB 18,377 Attenuates Mucositis Induced by 5-Fluorouracil in Mice.

Authors:  Joana O P A Coutinho; Mônica F Quintanilha; Marina R A Campos; Enio Ferreira; Graciéle C A de Menezes; Luiz H Rosa; Carlos A Rosa; Katia D Vital; Simone O A Fernandes; Valbert N Cardoso; Jacques R Nicoli; Fabiana C P Tiago; Flaviano S Martins
Journal:  Probiotics Antimicrob Proteins       Date:  2021-07-13       Impact factor: 5.265

9.  Amelioration of Chemotherapy-Induced Intestinal Mucositis by Orally Administered Probiotics in a Mouse Model.

Authors:  Chun-Yan Yeung; Wai-Tao Chan; Chun-Bin Jiang; Mei-Lien Cheng; Chia-Yuan Liu; Szu-Wen Chang; Jen-Shiu Chiang Chiau; Hung-Chang Lee
Journal:  PLoS One       Date:  2015-09-25       Impact factor: 3.240

10.  Pretreatment with Saccharomyces boulardii does not prevent the experimental mucositis in Swiss mice.

Authors:  Tatiani Uceli Maioli; Brenda de Melo Silva; Michelle Nobre Dias; Nivea Carolina Paiva; Valbert Nascimento Cardoso; Simone Odilia Fernandes; Cláudia Martins Carneiro; Flaviano Dos Santos Martins; Simone de Vasconcelos Generoso
Journal:  J Negat Results Biomed       Date:  2014-04-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.